(Q33535928)

27 July 2017

1 reference

title

Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts (English)

1 reference

27 July 2017

1 reference

Orbaek Andersen H

1

1 reference

27 July 2017

publication date

1 February 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

142

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

243-263

1 reference

Immune mechanisms of cardiac allograft vasculopathy: an update

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Long-term complications of cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Pathologic pulmonary alterations in long-term human heart-lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Experience of percutaneous transluminal coronary angioplasty in orthotopic cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Transplant coronary artery disease: histopathologic correlations with angiographic morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary Artery Narrowing in Coronary Heart Disease: Comparison of Cineangiographic and Necropsy Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Acute myocardial infarction in cardiac transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Morphology of graft arteriosclerosis in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Ultrastructural evidence of cell-mediated endothelial cell injury in cardiac transplant-related accelerated arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Perforin expression localizing cytotoxic lymphocytes in the intimas of coronary arteries with transplant-related accelerated arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Murine model of accelerated transplant arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Chronic allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Pathogenesis and treatment perspectives of chronic graft rejection (CVR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

The influence of rejection episodes on the development of coronary artery disease after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Role of angiotensin subtype 2 receptor in neointima formation after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Effect of pravastatin on outcomes after cardiac transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Signals and signs for lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

The molecular cell biology of interferon-gamma and its receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Lymphocyte responses and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cyclosporin A, FK506 and rapamycin: more than just immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Adhesion receptors of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Lymphocyte interactions with endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Macrophage activation by T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Increased endothelin expression in a rat cardiac allograft model of chronic vascular rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: antiproliferative effects of bosentan, a nonselective endothelin receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

In vivo blockade of tumor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Dose-dependent suppression of transplant arteriosclerosis in aorta-allografted, cholesterol-clamped rabbits. Suppression not eliminated by the cholesterol-raising effect of cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Effect of cyclosporine during initiation of transplant arteriosclerosis. An ultrastructural study in the aorta-transplanted rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Endothelial loss and regeneration in a model of transplant arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Participation of dendritic cells in vascular lesions of chronic rejection of human allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Regulation of differentiated properties and proliferation of arterial smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Relative importance of ischemic injury and immunological injury on the development of transplant arteriosclerosis in rabbit aortic allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

The pathogenesis of atherosclerosis--an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Hyperlipidemia in solid organ transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Anti-endothelial antibodies and coronary artery disease after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cardiac allograft vasculopathy: IgM antibody responses to donor-specific vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

HLA compatibility and cardiac transplant recipient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Histocompatibility and other risk factors for histological rejection of human cardiac allografts during the first three months following transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Reversibility of allograft arteriosclerosis after retransplantation to donor strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Acute Rejection Accelerates Graft Coronary Disease in Transplanted Rabbit Hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cyclosporine-associated chronic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Immunosuppressive treatment of aortic allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

The effects of treatment on the arterial lesions of rat and rabbit cardiac allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Long-term consequences of different immunosuppressive regimens for renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Liver, kidney, and thoracic organ transplantation under FK 506.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Graft vessel disease: the impact of immunosuppression and possible treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Leflunomide interferes with pyrimidine nucleotide biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Relationship between sex hormones and haemostatic factors in healthy middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Immune mechanisms in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Is atherosclerosis an immunologically mediated disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Prevalence of hyperlipidemia in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Hyperlipidemia after cardiac transplantation: be aware and possibly wary of drug therapy for lowering of serum lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Frequency of hypercholesterolemia after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Lipoprotein(a) and apolipoprotein changes after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Hyperlipidemia accelerates allograft arteriosclerosis (chronic rejection) in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Accelerated cholesterol accumulation in homologous arterial transplants in cholesterol-fed rabbits. A surgical model to study transplantation atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Enhanced accumulation and turnover of esterified cholesterol in injured rabbit aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Aortic permeability to LDL as a predictor of aortic cholesterol accumulation in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Efficacy and Pharmacokinetics of Simvastatin in Heart Transplant Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cholesterol-lowering intervention and coronary artery disease after cardiac transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Regression of transplant coronary artery disease during chronic HELP therapy: a case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Biologically modified LDL increases the adhesive properties of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Lipoprotein oxidation and lipoprotein-induced cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Modified forms of low-density lipoprotein and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Increased lipid peroxidation in cyclosporin-treated heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Allograft-induced arterial wall injury and response in normotensive and spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

ACE-inhibitors and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Dose response of fish oil versus safflower oil on graft arteriosclerosis in rabbit heterotopic cardiac allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Estrogen and cardiovascular function after menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Effect of oestrogen replacement therapy on development of experimental arteriosclerosis: a study in transplanted and balloon-injured rabbit aortas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Effects of estradiol on myointimal thickenings from catheter injury and on organizing white mural non-occlusive thrombi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Angiopeptin, a somatostatin-14 analogue, decreases adhesiveness of rat leukocytes to unstimulated and IL-1 beta-activated rat heart endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Angiopeptin, the octapeptide analogue of somatostatin, decreases rat heart endothelial cell adhesiveness for mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary angioplasty following cardiac transplantation: a case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Successful coronary artery bypass grafting for high-risk left main coronary artery atherosclerosis after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary artery bypass grafting nine years after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Percutaneous coronary angioplasty in a cardiac transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Reversal of ischemic myocardial dysfunction by PTCA in a cardiac transplant patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary angioplasty in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary angioplasty in cardiac transplant patients. Results of a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Retransplantation for severe accelerated coronary artery disease in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Sequential immunological targeting of chronic experimental arterial allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Experimental graft arteriosclerosis. II. Immunocytochemical analysis of lesion development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Gene therapy for donor hearts: ex vivo liposome-mediated transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

Coronary venous intimal thickening in explanted cardiac allografts. Evidence demonstrating that transplant coronary artery disease is a manifestation of a diffuse allograft vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

Chronic vascular rejection of the heart and the kidney--have rational treatment options emerged?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

Association of acidic fibroblast growth factor and untreated low grade rejection with cardiac allograft vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

Immunosuppression in cardiac transplantation: a new era in immunopharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

Principles of solid-organ preservation by cold storage

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

Induction of T-cell activation by oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

Effects of Probucol on Hyperlipidemic Patients with Cardiac Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900291-3

7 January 2021

10.1016/S0021-9150(98)00291-3

Identifiers

DOI

1 reference

27 July 2017

1 reference